NFKB1 and bacterial infectious disease: Taking the occurrence of bacterial superinfections in IV-infected individuals and the multilayered interplays of those viral and bacterial invaders into account, it is necessary to address whether the blockade of a central cell intrinsic innate immune regulator such as NF-κB as anti-IV approach may come at the cost of sensitizing lung epithelial cells to secondary bacterial infections.